H.Res. 803 · 119th Congress · House

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Active· Submitted in House
Introduced
Oct 10, 25
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Bill Text Versions

1

Introduced in House

Published: October 10, 2025

USLM Available
View Text